CD44 and neoplasm: Aldehyde dehydrogenase (ALDH) is another well-accepted cell-surface marker for BCSCs [12], and studies have reported that ALDH+ BCSCs manifest intensified colony formation, tumor initiation, and chemo-resistance than CD44+/CD24− BCSCs [13].